1 Min Read
May 2 (Reuters) - Blueprint Medicines Corp:
* BLUEPRINT MEDICINES REPORTS FIRST QUARTER 2018 FINANCIAL RESULTS
* Q1 EARNINGS PER SHARE VIEW $-1.13 — THOMSON REUTERS I/B/E/S Source text for Eikon: Further company coverage:
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2018 Reuters. All Rights Reserved.